Granahan Investment Management, LLC Iterum Therapeutics PLC Transaction History

Granahan Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$1.19 - $4.38 $286,933 - $1.06 Million	-241,121 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$1.55 - $4.56 $5,186 - $15,257	-3,346 Reduced 1.37%	241,121 $653,000
Q4 2019 Feb 14, 2020	BUY	$1.7 - $5.99 $3,809 - $13,423	2,241 Added 0.93%	244,467 $1.1 Million
Q3 2019 Nov 15, 2019	BUY	$5.77 - $7.65 $54,007 - $71,604	9,360 Added 4.02%	242,226 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$6.09 - $9.1 $6,504 - $9,718	1,068 Added 0.46%	232,866 $1.6 Million
Q1 2019 May 14, 2019	SELL	$4.88 - $8.17 $70,774 - $118,489	-14,503 Reduced 5.89%	231,798 $1.84 Million
Q4 2018 Feb 13, 2019	SELL	$5.01 - $7.9 $22,124 - $34,886	-4,416 Reduced 1.76%	246,301 $1.23 Million
Q3 2018 Nov 13, 2018	BUY	$6.24 - $10.4 $61,570 - $102,616	9,867 Added 4.1%	250,717 $1.66 Million
Q2 2018 Aug 15, 2018	BUY	$10.67 - $12.85 $2.57 Million - $3.09 Million	240,850 New	240,850 $2.57 Million

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $15.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Granahan Investment Management, LLC with notifications on news.